Tag

trial

1 minuto di lettura

Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

(Adnkronos) – SHANGHAI, June 30, 2023 /PRNewswire/ — Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded,

Immediapress

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

(Adnkronos) – The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam:

Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter

Immediapress

(Adnkronos) – LAGUNA HILLS, Calif., May 3, 2023 /PRNewswire/ — Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF)

First Clinical Study of its Kind Shows Positive Impacts from Astaxanthin During Sport Recovery

Immediapress

(Adnkronos) – BRANCHBURG, N.J., March 28, 2023 /PRNewswire/ — A new clinical trial study, published in Frontiers in Nutrition, showed that four weeks of

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

martedì, 16 Gennaio 2024

Immediapress

(Adnkronos) – CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ — Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial,

Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors

martedì, 5 Dicembre 2023

Immediapress

(Adnkronos) – The company announces the first patient dosed in a Phase 1/1b clinical trial evaluating its novel IL-2 cytokine, DF6215, the seventh Dragonfly-developed drug to enter into clinical trials. WALTHAM, Mass.,

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation

giovedì, 16 Novembre 2023

Immediapress

(Adnkronos) – LONDON, Nov. 16, 2023 /PRNewswire/ — The US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA) have approved Kanna Health’s Investigational New Drug (IND)

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

mercoledì, 8 Novembre 2023

Immediapress

(Adnkronos) – LONDON, ON, Nov. 8, 2023 /PRNewswire/ — Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine and artificial intelligence (AI)-enabled

BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate

martedì, 7 Novembre 2023

Immediapress

(Adnkronos) – SHANGHAI, Nov. 7, 2023 /PRNewswire/ — BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the first patient has been dosed in the Phase I Clinical trial of

European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer

giovedì, 19 Ottobre 2023

Immediapress

(Adnkronos) – BRUSSELS and FLORENCE, Italy, Oct. 19, 2023 /PRNewswire/ — The European Organisation for Research and Treatment of Cancer (EORTC) and the Menarini Group (Menarini), a leading international pharmaceutical and diagnostics company,

Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials

martedì, 10 Ottobre 2023

Immediapress

(Adnkronos) – LONDON, ON and VANCOUVER, BC, Oct. 10, 2023 /PRNewswire/ — Alimentiv, a global contract research organization (CRO) providing clinical trials, central image management, precision medicine, and real-world evidence services to the

Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial

lunedì, 9 Ottobre 2023

Immediapress

(Adnkronos) – NAPERVILLE, Ill., Oct. 9, 2023 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

giovedì, 14 Settembre 2023

Immediapress

(Adnkronos) – LAGUNA HILLS, Calif., Sept. 14, 2023 /PRNewswire/ — Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the first ultra-low

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

giovedì, 14 Settembre 2023

Immediapress

1 2 3 Avanti

trial

Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter

First Clinical Study of its Kind Shows Positive Impacts from Astaxanthin During Sport Recovery

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate

European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer

Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials

Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

Primo piano

Dopo gli scontri: cosa prevede il decreto e quali poteri hanno i militari

Il gioco sporco de “la Repubblica” che evoca il Cile di Pinochet in Italia

Schlein: “Serve prevenzione non repressione su sicurezza. Colle ha stoppato poteri ai militari” | Video

Tajani: “A lavoro per autotrasporti. Poteri ai militari? Stop dal Colle, io ero favorevole” | Video

Milano si prepara a un weekend ad alta tensione: ecco come

Sponsor

Suggerimenti

trial

Primo piano

Sponsor